ACTIVAC
Device
KCI USA, Inc
Total Payments
$656,091
Transactions
2,765
Doctors
2,082
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $200,795 | 576 | 513 |
| 2019 | $111,202 | 950 | 827 |
| 2018 | $181,014 | 483 | 426 |
| 2017 | $163,079 | 756 | 609 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $404,525 | 15 | 61.7% |
| Food and Beverage | $81,035 | 2,617 | 12.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $76,499 | 12 | 11.7% |
| Consulting Fee | $55,107 | 51 | 8.4% |
| Travel and Lodging | $20,440 | 63 | 3.1% |
| Education | $10,485 | 6 | 1.6% |
| Grant | $8,000 | 1 | 1.2% |
Payments by Type
Research
$404,525
15 transactions
General
$251,566
2,750 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Intellicure - Post-market clinical follow-up data collection | KCI USA, Inc. | $160,000 | 1 |
| Multicenter randomized controlled trial of a negative pressure incision management system in high risk vascular surgery patients | KCI USA, Inc | $78,480 | 0 |
| Evaluation of Negative Pressure Wound Therapy for Reduction of Postoperative Surgical Site Infection in Patients Undergoing Colorectal and Hepatopancreatobiliary Surgery | KCI USA, Inc | $68,231 | 0 |
| Muticenter, Prospective, Randomized Clinical Trial of a Negative Pressure Incision Management System in High Risk Vascular Surgery Patients | KCI USA, Inc | $32,400 | 0 |
| Prophylactic Negative Pressure Wound Therapy in Obese Women at Cesarean a multicenter Randomized Trial | KCI USA, Inc | $20,000 | 0 |
| Closed Incision Negative Pressure Therapy Versus Standard of Care Surgical Dressing in Revision Total Knee Arthroplasty PROMISES | KCI USA, Inc | $18,739 | 0 |
| Closed Incision Negative Pressure Therapy in Ventral Hernia Repair with Simultaneous Panniculectomy | KCI USA, Inc | $18,000 | 0 |
| External VAC Therapy Improves Perfusion in a Pig Model | KCI USA, Inc | $8,675 | 0 |
Top Doctors Receiving Payments for ACTIVAC — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Surgery | Celebration, FL | $1,325 | 2 |
| , M.D | Plastic Surgery | Lake Mary, FL | $1,325 | 2 |
| , M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Orlando, FL | $1,200 | 1 |
| , DPM | Foot & Ankle Surgery | Columbus, OH | $1,180 | 7 |
| , M.D | Surgery | Kissimmee, FL | $1,100 | 2 |
| , MD | Trauma Surgery | Tyler, TX | $985.45 | 3 |
| , M.D | Colon & Rectal Surgery | Tampa, FL | $925.37 | 2 |
| , M.D | Orthopaedic Surgery | Wesley Chapel, FL | $925.37 | 2 |
| , M.D | Orthopaedic Surgery | Wesley Chapel, FL | $925.37 | 2 |
| , D.P.M | Podiatrist | Boynton Beach, FL | $848.37 | 4 |
| , M.D | Infectious Disease | Zephyrhills, FL | $807.79 | 4 |
| , M.D | Surgery | Chicago, IL | $800.00 | 1 |
| , D.O | Family Medicine | Flagstaff, AZ | $782.82 | 3 |
| Alexander Rosemurgy | — | Tampa, FL | $775.37 | 2 |
| , M.D | Surgery | Zephyrhills, FL | $775.37 | 2 |
| , DPM, CEO | Foot & Ankle Surgery | Poway, CA | $698.88 | 4 |
| , D.O | Surgery | Las Vegas, NV | $682.39 | 2 |
| , MD | Surgical Critical Care | Saint Louis, MO | $675.00 | 1 |
| , MD | Surgery | Tampa, FL | $650.00 | 1 |
| , DPM | Foot Surgery | Zephyrhills, FL | $625.37 | 2 |
| , DPM | Podiatrist | Greenville, SC | $622.46 | 2 |
| , MD | Vascular Surgery | Durham, NC | $550.00 | 1 |
| , MD | Family Medicine | Henderson, NV | $528.96 | 3 |
| , MD | Internal Medicine | San Antonio, TX | $503.35 | 7 |
| , MD | Undersea and Hyperbaric Medicine | Austin, TX | $500.00 | 1 |
Ad
Manufacturing Companies
- KCI USA, Inc $455,296
- KCI USA, Inc. $200,795
Product Information
- Type Device
- Total Payments $656,091
- Total Doctors 2,082
- Transactions 2,765
About ACTIVAC
ACTIVAC is a device associated with $656,091 in payments to 2,082 healthcare providers, recorded across 2,765 transactions in the CMS Open Payments database. The primary manufacturer is KCI USA, Inc.
Payment data is available from 2017 to 2020. In 2020, $200,795 was paid across 576 transactions to 513 doctors.
The most common payment nature for ACTIVAC is "Unspecified" ($404,525, 61.7% of total).
ACTIVAC is associated with 8 research studies, including "Intellicure - Post-market clinical follow-up data collection" ($160,000).